Vadodara, India

Hiral Shah

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Alembic Pharmaceuticals Limited. Active years: 2015.


 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hiral Shah: Innovator in Pharmaceutical Processes

Introduction

Hiral Shah is a prominent inventor based in Vadodara, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. With a total of 2 patents, her work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Hiral Shah's latest patents include a process for preparing Fesoterodine and a process for preparing Deferasirox. The first patent relates to an improved method for the preparation of Fesoterodine and its pharmaceutically acceptable salts. This innovative process involves the use and preparation of R(+)benzyl tolterodine and fumarate salt of R(+)-[4-benzyloxy-3-(3-diisopropylamino-1-phenylpropyl)-phenyl]-methanol. The second patent provides an improved process for the preparation of Deferasirox, which is crucial for its effective application in medical treatments.

Career Highlights

Hiral Shah is currently associated with Alembic Pharmaceuticals Limited, where she continues to advance her research and development efforts. Her work at Alembic has allowed her to focus on innovative pharmaceutical processes that enhance drug efficacy and safety.

Collaborations

Hiral collaborates with notable colleagues, including Jayaraman Venkat Raman and Samir Patel. These collaborations foster a creative environment that encourages the exchange of ideas and expertise in pharmaceutical innovations.

Conclusion

Hiral Shah's contributions to the pharmaceutical industry through her innovative processes exemplify her dedication to improving drug preparation methods. Her patents not only reflect her expertise but also her commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…